Biography and Research Information
OverviewAI-generated summary
Madeline Fulmer is a graduate student at the University of Arkansas for Medical Sciences. Her research focuses on the discovery and characterization of novel compounds for therapeutic applications. Fulmer recently published work on the DNA-PKcs inhibitor DA-143, a compound that exhibits improved solubility compared to the existing inhibitor NU7441. This research contributes to the ongoing effort to develop more effective treatments for diseases involving DNA repair pathways, such as cancer. Fulmer collaborates with researchers including Randall R Rainwater, Brendan Frett, Ana Clara P. Azevedo‐Pouly, and Baku Acharya at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 1
- Publications: 1
- Citations: 2
Selected Publications
-
Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441 (2024)
Collaboration Network
Top Collaborators
Zachary J. Waldrip
Arkansas Children's Hospital (US)
1 shared publication
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Baku Acharya
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Daniel W. Armstrong
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Maha Hanafi
Cairo University (EG)
1 shared publication
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Randall R Rainwater
Arkansas Children's Hospital
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Sharon Amole
University of Arkansas for Medical Sciences (US)
1 shared publication
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Ana Clara P. Azevedo‐Pouly
Arkansas Children's Hospital
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Alaina Burns
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Lyle Burdine
University of Arkansas for Medical Sciences (US)
1 shared publication
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Brendan Frett
University of Arkansas for Medical Sciences
1 shared publication
In database
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Marie Burdine
Arkansas Children's Nutrition Center (US)
1 shared publication
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Similar Researchers
Based on overlapping research topics
Yuxi Li
National Center for Toxicological Research
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Brendan Frett
University of Arkansas for Medical Sciences
Drug Discovery and Development
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Alan Herrera-Rueda
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies
Mathew Newman
Arkansas State University
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies
Qudes Al-Anbaky
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Li Han
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Molecular Biology Techniques and Applications
Pharmacological Effects and Toxicity Studies